The most common side effects during the IGF-1 treatment phase were sleep disturbance (N = 7); hypoglycemia ((<50 mg/dL) (7 occurrences; N = 5)), constipation (N = 4), increased appetite (N = 4), and mood changes or increased irritability (N = 4). Here, IGF1 is linked to Hypoglycemia.